Comparison Overview

ExecuPharm

VS

Alkem Laboratories Ltd.

ExecuPharm

610 Freedom Business Center Drive, King of Prussia, 19406, US
Last Update: 2025-12-17
Between 750 and 799

ExecuPharm is the North American clinical operations business of Parexel FSP. 10+ years of Experience Meeting Client Needs 10,000+ Global Clinical Operational Specialists In Network 80% of Recruiting Staff with >15 Years of Experience Talent Acquisition, Deployment Rates, and Employee Retention above 90% Management Staff with Tangible Industry Experience Greater Than 95% Repeat Business Average Turnaround Time of 14 Days To Deploy Project Team Resources

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 297
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
2

Alkem Laboratories Ltd.

Lower Parel, Alkem House , Mumbai, IN, 400013
Last Update: 2025-12-17
Between 750 and 799

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 15,251
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/parexelfsp.jpeg
ExecuPharm
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/alkem-laboratories-ltd.jpeg
Alkem Laboratories Ltd.
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
ExecuPharm
100%
Compliance Rate
0/4 Standards Verified
Alkem Laboratories Ltd.
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for ExecuPharm in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Alkem Laboratories Ltd. in 2025.

Incident History — ExecuPharm (X = Date, Y = Severity)

ExecuPharm cyber incidents detection timeline including parent company and subsidiaries

Incident History — Alkem Laboratories Ltd. (X = Date, Y = Severity)

Alkem Laboratories Ltd. cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/parexelfsp.jpeg
ExecuPharm
Incidents

Date Detected: 10/2025
Type:Vulnerability
Blog: Blog

Date Detected: 6/1994
Type:Ransomware
Motivation: Financial
Blog: Blog
https://images.rankiteo.com/companyimages/alkem-laboratories-ltd.jpeg
Alkem Laboratories Ltd.
Incidents

No Incident

FAQ

Alkem Laboratories Ltd. company demonstrates a stronger AI Cybersecurity Score compared to ExecuPharm company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

ExecuPharm company has historically faced a number of disclosed cyber incidents, whereas Alkem Laboratories Ltd. company has not reported any.

In the current year, ExecuPharm company has reported more cyber incidents than Alkem Laboratories Ltd. company.

ExecuPharm company has confirmed experiencing a ransomware attack, while Alkem Laboratories Ltd. company has not reported such incidents publicly.

Neither Alkem Laboratories Ltd. company nor ExecuPharm company has reported experiencing a data breach publicly.

Neither Alkem Laboratories Ltd. company nor ExecuPharm company has reported experiencing targeted cyberattacks publicly.

ExecuPharm company has disclosed at least one vulnerability, while Alkem Laboratories Ltd. company has not reported such incidents publicly.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds any compliance certifications.

Neither company holds any compliance certifications.

ExecuPharm company has more subsidiaries worldwide compared to Alkem Laboratories Ltd. company.

Alkem Laboratories Ltd. company employs more people globally than ExecuPharm company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds SOC 2 Type 1 certification.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds SOC 2 Type 2 certification.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds ISO 27001 certification.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds PCI DSS certification.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds HIPAA certification.

Neither ExecuPharm nor Alkem Laboratories Ltd. holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.

Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.

Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description

Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.

Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X